SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-025396
Filing Date
2023-07-24
Accepted
2023-07-24 17:28:38
Documents
15
Period of Report
2023-07-24
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 75231
2 ex3-1.htm EX-3.1 8269
3 ex99-1.htm EX-99.1 18536
4 ex99-1_001.jpg GRAPHIC 2577
  Complete submission text file 0001493152-23-025396.txt   291066

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ocx-20230724.xsd EX-101.SCH 3012
6 XBRL LABEL FILE ocx-20230724_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ocx-20230724_pre.xml EX-101.PRE 22358
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3282
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 231105933
SIC: 2835 In Vitro & In Vivo Diagnostic Substances